The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 ( FGF23) in Chronic Kidney Disease

Clinical trial NCT01002872 · COMPLETED

Trial details

NCT number: NCT01002872
Sponsor: Endeavor Health
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Metabolic Bone Disease

Start date: 2009-10-01
Primary completion: 2012-05-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.